Zehtab S, Sattarzadeh Bardsiri M, Mirzaee Khalilabadi R, Ehsan M, Fatemi A. Association of DNA repair genes polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis. BMC Res Notes. 2022;15:46. https://doi.org/10.1186/s13104-022-05918-3.
Deng Q, Yue S, You F, Zhai Z, Sun H, Liang L, et al. Vincristine/Volasertib polymersome injection enables high-efficiency synergistic treatment of acute lymphoblastic leukemia. Acta Biomater. 2025;200:641–52. https://doi.org/10.1016/j.actbio.2025.05.041.
Ekpa QL, Akahara PC, Anderson AM, Adekoya OO, Ajayi OO, Alabi PO, et al. A review of acute lymphocytic leukemia (ALL) in the pediatric population: evaluating current trends and changes in guidelines in the past decade. Cureus. 2023;15:e49930. https://doi.org/10.7759/cureus.49930.
Abobakr A, Osman RA, Kamal MA, Abdelhameed S, Ismail H, Kamel MM, et al. Clinical and prognostic significance of CD27 and CD44 expression patterns in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia. Hematol Transfus Cell Ther. 2024;46:S27–35. https://doi.org/10.1016/j.htct.2023.10.003.
Hassib AE, Abdulhafeez DM, Atef NA, Ameen OM. The role of miRNA-196a2 genotypes in the susceptibility of acute lymphoblastic leukemia in Egyptian children. Gene Rep. 2021;24:101237. https://doi.org/10.1016/j.genrep.2021.101237.
Zhu J, Lu J, He Y, Shen X, Xia H, Li W, et al. Association of ABCB1 polymorphisms with efficacy and adverse drug reactions of valproic acid in children with epilepsy. Pharmaceuticals. 2023;16:1536. https://doi.org/10.3390/ph16111536.
Skinner KT, Palkar AM, Hong AL. Genetics of ABCB1 in cancer. Cancers (Basel). 2023;15:4236. https://doi.org/10.3390/cancers15174236.
Zintzaras E. Is there evidence to claim or deny association between variants of the multidrug resistance gene (MDR1 or ABCB1) and inflammatory bowel disease? Inflamm Bowel Dis. 2012;18:562–72. https://doi.org/10.1002/ibd.21728.
Gregers J, Green H, Christensen IJ, Dalhoff K, Schroeder H, Carlsen N, et al. Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia. Pharmacogenomics J. 2015;15:372–9. https://doi.org/10.1038/tpj.2014.81.
Sági JC, Gézsi A, Egyed B, Jakab Z, Benedek N, Attarbaschi A, et al. Pharmacogenetics of the central nervous system—toxicity and relapse affecting the CNS in pediatric acute lymphoblastic leukemia. Cancers (Basel). 2021;13:2333. https://doi.org/10.3390/cancers13102333.
Khosravi M, Khalaj Z, Nouri N, Najaflu M, Mehrzad V, Forat-Yazdi M, et al. Lack of association between c1236t, g2677t/a and c3435t variants of the abcb1 gene and Imatinib response in Iranian chronic myeloid leukemia patients. J Sci I R I. 2021;32:121–30. https://doi.org/10.22059/jsciences.2021.313865.1007595.
Alkanli N, Ay A, Cevik G. Investigation of the roles of IL-18 (-607 C > A) and IL-18 (-137 G > C) gene variations in bladder cancer development: case–control study. J Cancer Res Clin Oncol. 2021;147:3627–37. https://doi.org/10.1007/s00432-021-03808-y.
Aghajani R, Saeidi M, Amiriani T, Marjani M, Amiriani AH, Akhavan Tabib A, Marjani A. Genetic polymorphisms – 137 (G > C)(rs187238) and – 607 (C > A)(rs1946518) and serum level of Interleukin 18 in Fars ethnic groups with metabolic syndrome in Northern Iran. Arch Physiol Biochem. 2022;128:1596–602. https://doi.org/10.1080/13813455.2020.1784954.
Wadea FM, Abdou AE, Abd-El Monem DM, Sharafeddin MA. Clinical significance of Interleukin 18 in chronic liver disease. J Hosp Med. 2022;89:4430–3. https://doi.org/10.21608/ejhm.2022.258456.
Shen J, Zhang Y, Tang W, Yang M, Cheng T, Chen Y, et al. Short IL-18 generated by caspase-3 cleavage mobilizes NK cells to suppress tumor growth. Nat Immunol. 2025;26:416–28. https://doi.org/10.1038/s41590-024-02074-7.
Qu R, Zhao Y, Zhang Y. The mechanism of cytokine regulation of cancer occurrence and development in the tumor microenvironment and its application in cancer treatment: a narrative review. Transl Cancer Res. 2024;13:5649–63. https://doi.org/10.21037/tcr-24-679.
Ma T, Kong M. Interleukin-18 and – 10 may be associated with lymph node metastasis in breast cancer. Oncol Lett. 2021;21:253. https://doi.org/10.3892/ol.2021.12515.
Zhang Z, Wang J, Teng M, Yan X, Liu Q. The role of serum interleukins in cancer: a multi-center Mendelian randomization study. Int Immunopharmacol. 2024;137:112520. https://doi.org/10.1016/j.intimp.2024.112520.
Sakharkar P, Deb S, Mashayekhi N. Association between polymorphisms in cytokine gene and viral infections in renal and liver transplant recipients: a systematic review. J Pharm Pharm Sci. 2020;23:109–31. https://doi.org/10.18433/jpps30961.
Martinez Valenzuela L, Vidal-Alabró A, Rubio B, Antón-Pàmpols P, Gómez-Preciado F, Fulladosa X, et al. Evaluating single-nucleotide polymorphisms in inflammasome proteins and serum levels of IL-18 and IL-1β in kidney interstitial damage in anti-neutrophilic cytoplasmic antibody-associated vasculitis. Int J Mol Sci. 2024;25:6479. https://doi.org/10.3390/ijms25126479.
Solati H, Zareinejad M, Ghavami A, Ghasemi Z, Amirghofran Z. IL-35 and IL-18 serum levels in children with acute lymphoblastic leukemia: the relationship with prognostic factors. J Pediatr Hematol Oncol. 2020;42:281–6. https://doi.org/10.1097/MPH.0000000000001667.
Elmrghni S. DNA extraction from blood stored on FTA cards. European Journal of Medical and Health Research. 2024;2:4–8. https://doi.org/10.59324/ejmhr.2024.2(1).01.
Rahaman M, Mukherjee M, Chakravorty N, Genetic, Disorders. Genotyping techniques and the emerging role of Tetra-ARMS-PCR as a diagnostic tool. Resonance. 2021;26:1229–40. https://doi.org/10.1007/s12045-021-1225-x.
Nguyen TP, Tran AN, Nguyen TP, Cao NT, Khang T, Tran KT. Optimized T-ARMS PCR for detecting CYP2C19*2 polymorphism in the Mekong delta Khmer population. Arch Balk Med Union. 2024;59:343–51. https://doi.org/10.31688/ABMU.2024.59.4.03.
Hasan LO, Rasheed TK. Association of Interleukin-12 and Interleukin-18 polymorphisms with acute lymphoblastic leukemia disease in Iraqi patients. Iraqi J Sci. 2024;675–83. https://doi.org/10.24996/ijs.2024.65.2.8.
Birbian N, Singh J, Jindal SK. Protective role of IL-18 – 137G > C polymorphism in a North Indian population with asthma: A pilot study. Cytokine. 2013;61:188–93. https://doi.org/10.1016/j.cyto.2012.09.015.
Álvarez-Carrasco P, Morales-Villamil F, Maldonado-Bernal C. P-glycoprotein as a therapeutic target in hematological malignancies: a challenge to overcome. Int J Mol Sci. 2025;26:4701. https://doi.org/10.3390/ijms26104701.
Ohsawa M, Ikura Y, Fukushima H, Shirai N, Sugama Y, Suekane T, et al. Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma. Oncology. 2005;68:422–31. https://doi.org/10.1159/000086984.
Ammar M, Ktari S, Medhaffar M, Ghozzi H, Elloumi M, Hammami A, et al. MDR1 haplotypes and G2677T/A polymorphism predict Imatinib response in Tunisian patients with chronic myeloid leukemia. J Biosci Med. 2022;10:118–31. https://doi.org/10.4236/jbm.2022.109009.
Mijac D, Vukovic-Petrovic I, Mijac V, Perovic V, Milic N, Djuranovic S, et al. MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease. PLoS ONE. 2018;13:e0194536. https://doi.org/10.1371/journal.pone.0194536.
Fu R, Tajima S, Suetsugu K, Watanabe H, Egashira N, Masuda S. Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation. Acta Pharmacol Sin. 2019;40:151–9. https://doi.org/10.1038/s41401-018-0070-2.
Yan Y, Liang H, Xie L, He Y, Li M, Li R, et al. Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis. Tumor Biol. 2014;35:2191–7. https://doi.org/10.1007/s13277-013-1291-0.
Ihim SA, Abubakar SD, Zian Z, Sasaki T, Saffarioun M, Maleknia S, et al. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment. Front Immunol. 2022;13:919973. https://doi.org/10.3389/fimmu.2022.919973.
Terwilliger T, Abdul-Hay MJ. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7:e577. https://doi.org/10.1038/bcj.2017.53.
Landy E, Carol H, Ring A, Canna S. Biological and clinical roles of IL-18 in inflammatory diseases. Nat Rev Rheumatol. 2024;20:33–47. https://doi.org/10.1038/s41584-023-01053-w.
Arumugam D, Semalaiyappan J, Mookiah B, Kuttiatt VS. Genetic polymorphisms of IL-18 and their association with infectious Diseases–An update. Curr Genet Med Rep. 2025;13:1–2. https://doi.org/10.1007/s40142-025-00215-4.
Al-ardawy YJ, Al-Saadi AH, Alkindy MA, Al-Lsawi AM, Fadheel MA. Study of the relationship between genetic variants of IL-18 and the occurrence of inflammatory bowel disease. Egypt J Med Hum Genet. 2024;25:81. https://doi.org/10.1186/s43042-024-00555-w.
Yang X, Qiu MT, Hu JW, Jiang F, Li M, Wang J, et al. Association of interleukin-18 gene promoter – 607 C > A and – 137G > C polymorphisms with cancer risk: a meta-analysis of 26 studies. PLoS ONE. 2013;8:e73671. https://doi.org/10.1371/journal.pone.0073671.
Chen CC, Tzeng HE, Kuo CC, Lim SN, Hsu PC, Hsu YN, et al. Significant contribution of interleukin-18 genotypes to childhood acute lymphocytic leukemia risk in Taiwanese. Anticancer Res. 2022;42:5283–90. https://doi.org/10.21873/anticanres.16035.
Yalçın S, Mutlu P, Çetin T, Sarper M, Özgür G, Avcu F. The-137G > C polymorphism in interleukin-18 gene promoter contributes to chronic lymphocytic and chronic myelogenous leukemia risk in Turkish patients. Turk J Haematol. 2015;32:311–6. https://doi.org/10.4274/tjh.2014.0126.
Lau HK, Hsieh MJ, Yang SF, Wang HL, Kuo WH, Lee HL, et al. Association between interleukin-18 polymorphisms and hepatocellular carcinoma occurrence and clinical progression. Int J Med Sci. 2016;13:556–61. https://doi.org/10.7150/ijms.15853.
Zhu M, Rong X, Li M, Wang S. IL-18 and IL-35 in the serum of patients with sepsis thrombocytopenia and the clinical significance. Exp Ther Med. 2020;19:1251–8. https://doi.org/10.3892/etm.2019.8347.
Wang Z, Gao ZM, Huang HB, Sun LS, Sun AQ, Li K. Association of IL-8 gene promoter – 251 A/T and IL-18 gene promoter – 137 G > C polymorphisms with head and neck cancer risk: a comprehensive meta-analysis. Cancer Manag Res. 2018;2589–604. https://doi.org/10.2147/CMAR.S165631.
Ali YB, El-Gahel HE, Abdel-Hakem NE, Gadalla ME, El-Hefnawy MH, El-Shahat M. Association between IL-18 and IL-6 gene polymorphisms and the risk of T1D in Egyptian children. J Diabetes Metab Disord. 2021;20:439–46. https://doi.org/10.1007/s40200-021-00763-w.